Scarica l'app Stockscreener
112.15
1.36%
1.51
Dopo l'orario di chiusura:
112.15
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Storia dei dividendi
Precedente Chiudi:
$110.64
Aprire:
$110.77
Volume 24 ore:
1.04M
Relative Volume:
0.61
Capitalizzazione di mercato:
$22.84B
Reddito:
$7.60B
Utile/perdita netta:
$1.08B
Rapporto P/E:
21.32
EPS:
5.26
Flusso di cassa netto:
$1.26B
1 W Prestazione:
+0.33%
1M Prestazione:
+7.78%
6M Prestazione:
+3.63%
1 anno Prestazione:
-15.43%
Intervallo 1D:
$110.44
$112.56
Intervallo di 1 settimana:
$109.33
$112.56
Portata 52W:
$97.69
$133.90
Zimmer Biomet Holdings Inc Stock (ZBH) Company Profile
Nome
Zimmer Biomet Holdings Inc
Settore
Industria
Telefono
(574) 267-6131
Indirizzo
345 EAST MAIN STREET, WARSAW, IN
Confronta ZBH con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ZBH
Zimmer Biomet Holdings Inc
|
112.15 | 22.84B | 7.60B | 1.08B | 1.26B | 5.26 |
|
ABT
Abbott Laboratories
|
131.35 | 227.80B | 41.95B | 13.40B | 6.35B | 7.65 |
|
BSX
Boston Scientific Corp
|
100.80 | 149.09B | 16.75B | 1.85B | 2.37B | 1.25 |
|
SYK
Stryker Corp
|
367.54 | 142.81B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
88.98 | 114.12B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
71.19 | 41.85B | 5.72B | 4.17B | 259.90M | 6.97 |
Zimmer Biomet Holdings Inc Stock (ZBH) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-12-17 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2024-09-10 | Iniziato | Wolfe Research | Peer Perform |
| 2024-07-01 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2024-05-30 | Iniziato | Goldman | Neutral |
| 2024-05-21 | Aggiornamento | Argus | Hold → Buy |
| 2024-01-04 | Downgrade | Evercore ISI | Outperform → In-line |
| 2023-10-20 | Iniziato | ROTH MKM | Neutral |
| 2023-08-28 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2023-05-03 | Aggiornamento | BofA Securities | Underperform → Neutral |
| 2023-04-11 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2023-03-31 | Aggiornamento | Jefferies | Underperform → Hold |
| 2023-03-29 | Iniziato | UBS | Sell |
| 2023-03-10 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2023-01-09 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
| 2023-01-05 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2023-01-03 | Downgrade | Evercore ISI | Outperform → In-line |
| 2022-11-23 | Aggiornamento | Wells Fargo | Underweight → Equal Weight |
| 2022-10-18 | Iniziato | Barclays | Underweight |
| 2022-10-12 | Iniziato | Jefferies | Underperform |
| 2022-05-27 | Downgrade | Needham | Buy → Hold |
| 2022-04-13 | Downgrade | Truist | Buy → Hold |
| 2022-04-01 | Downgrade | Citigroup | Buy → Neutral |
| 2022-03-02 | Ripresa | BofA Securities | Underperform |
| 2022-03-02 | Downgrade | Loop Capital | Buy → Hold |
| 2022-02-08 | Downgrade | Canaccord Genuity | Buy → Hold |
| 2022-02-08 | Reiterato | Citigroup | Buy |
| 2022-02-08 | Reiterato | Deutsche Bank | Hold |
| 2022-02-08 | Reiterato | JMP Securities | Mkt Outperform |
| 2022-02-08 | Reiterato | JP Morgan | Neutral |
| 2022-02-08 | Reiterato | RBC Capital Mkts | Sector Perform |
| 2022-02-08 | Reiterato | Stifel | Buy |
| 2022-02-08 | Reiterato | Truist | Buy |
| 2022-02-08 | Reiterato | UBS | Neutral |
| 2022-02-08 | Reiterato | Wells Fargo | Underweight |
| 2022-02-02 | Downgrade | UBS | Buy → Neutral |
| 2022-01-19 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| 2022-01-10 | Downgrade | Mizuho | Buy → Neutral |
| 2022-01-07 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2022-01-04 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2021-12-10 | Iniziato | RBC Capital Mkts | Sector Perform |
| 2021-12-09 | Downgrade | Needham | Strong Buy → Buy |
| 2021-12-07 | Iniziato | Loop Capital | Buy |
| 2021-11-23 | Downgrade | Argus | Buy → Hold |
| 2021-09-14 | Ripresa | Raymond James | Mkt Perform |
| 2021-05-25 | Iniziato | Barclays | Overweight |
| 2021-04-09 | Aggiornamento | Northland Capital | Market Perform → Outperform |
| 2021-01-04 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2020-12-18 | Reiterato | Needham | Strong Buy |
| 2020-10-20 | Iniziato | Northland Capital | Market Perform |
| 2020-09-11 | Iniziato | Wolfe Research | Outperform |
| 2020-08-05 | Reiterato | Needham | Strong Buy |
| 2020-04-28 | Downgrade | Guggenheim | Buy → Neutral |
| 2020-04-09 | Downgrade | Evercore ISI | Outperform → In-line |
| 2020-04-07 | Reiterato | Needham | Strong Buy |
| 2020-03-05 | Iniziato | Citigroup | Buy |
| 2020-02-13 | Iniziato | Goldman | Buy |
| 2020-01-08 | Iniziato | SunTrust | Buy |
| 2020-01-07 | Aggiornamento | Piper Jaffray | Neutral → Overweight |
| 2020-01-07 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2019-12-04 | Aggiornamento | Raymond James | Outperform → Strong Buy |
| 2019-10-07 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2019-09-18 | Aggiornamento | Canaccord Genuity | Hold → Buy |
| 2019-08-12 | Aggiornamento | Argus | Hold → Buy |
| 2019-07-30 | Aggiornamento | Barclays | Underweight → Equal Weight |
| 2019-07-29 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2019-06-11 | Aggiornamento | Bernstein | Underperform → Mkt Perform |
| 2019-04-24 | Aggiornamento | Needham | Buy → Strong Buy |
Mostra tutto
Zimmer Biomet Holdings Inc Borsa (ZBH) Ultime notizie
Ex-Dividend Reminder: PG&E, Zimmer Biomet Holdings and Ensign Group - Nasdaq
Goldman Sachs Adjusts PT on Zimmer Biomet Holdings to $120 From $115, Maintains Neutral Rating - Marketscreener.com
Looking Into Zimmer Biomet Holdings's Recent Short Interest - Benzinga
3 Promising Surgical Robotics Stocks to Keep an Eye on in 2025 - TradingView
Zimmer Holdings Q3 profit surges, cuts FY08 outlookupdate - RTTNews
Europe Viscosupplementation Market Set to Witness Significant - openPR
Is Zimmer Biomet Stock Outperforming the S&P 500? - TradingView
Reflecting On Surgical Equipment & ConsumablesDiversified Stocks’ Q4 Earnings: Zimmer Biomet (NYSE:ZBH) - Yahoo Finance
Spinal Fusion Device Market Forecast Report and Company Analysis 2025-2033 Featuring Medtronic, Stryker, Zimmer Biomet, Orthofix Medical, NuVasive, Globus Medical, Xtant Medical, and Alphatec – Ortho Spine News - OrthoSpineNews
Spinal Fusion Device Market Forecast Report and Company - GlobeNewswire
Zimmer Biomet Holdings (NYSE:ZBH) Has Announced A Dividend Of $0.24 - Simply Wall St
Zimmer Biomet Holdings (NYSE:ZBH) Is Due To Pay A Dividend Of $0.24 - Yahoo Finance
Zimmer Biomet Focuses on Innovation Amid Growing Competition - Yahoo Finance
Zimmer Biomet at Barclays Conference: Strategic Growth Insights By Investing.com - Investing.com South Africa
Proficio Capital Partners LLC Takes $55,000 Position in Zimmer Biomet Holdings, Inc. (NYSE:ZBH) - Defense World
Rep. Julie Johnson Sells Off Shares of Zimmer Biomet Holdings, Inc. (NYSE:ZBH) - Defense World
Zimmer Biomet at Barclays Conference: Strategic Growth Insights - Investing.com
Zimmer Q3 Sales Disappoint, Trims FY10 Sales Growth ForecastUpdate - RTTNews
Q3 EPS Estimates for Zimmer Biomet Lowered by Zacks Research - Defense World
Zimmer Biomet Focusing On Innovation Pipeline And Product Portfolio To Drive Growth - RTTNews
ZBH Stock to Gain From Global Expansion Amid Difficult FX Scenario - TradingView
Zimmer Biomet Holdings: Balancing Optimism with Caution Amid Strategic Growth and Market Challenges - TipRanks
Zimmer Biomet Holdings: Strategic Initiatives and Execution Risks Justify Hold Rating - TipRanks
Zimmer Biomet Q1 EPS Forecast Reduced by Zacks Research - Defense World
Paragon 28 clears regulatory hurdle in Zimmer Biomet merger By Investing.com - Investing.com Australia
Paragon 28 clears regulatory hurdle in Zimmer Biomet merger - Investing.com India
Paragon 28 Announces Expiration of HSR Act Waiting Period for Pending Acquisition by Zimmer Biomet Under HSR Act - Joplin Globe
Paragon 28 Acquisition by Zimmer Biomet Clears Major Regulatory Hurdle - StockTitan
Tissue Engineering Market Analysis, Competitive Intelligence, and Growth Opportunities to 2030Zimmer Biomet, Stryker Corporation, and 3D BioFibR Lead the Industry - GlobeNewswire
Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Stock Holdings Lowered by Steward Partners Investment Advisory LLC - Defense World
Zimmer Biomet Highlights Diverse Portfolio of Orthopedic & Musculoskeletal Innovations at AAOS 2025 Annual Meeting - PR Newswire
Zimmer Biomet Holdings, Inc. to Host Earnings Call - ACCESS Newswire
Mutual of America Capital Management LLC Decreases Holdings in Zimmer Biomet Holdings, Inc. (NYSE:ZBH) - Defense World
Zimmer Biomet SVP Lori Winkler sells $150,649 in stock By Investing.com - Investing.com Canada
Top Executive Cashes In on Zimmer Biomet Holdings Stock - TipRanks
Zimmer Biomet to Present at the 27th Annual Barclays Healthcare Conference - GuruFocus.com
Zimmer Biomet SVP Lori Winkler sells $150,649 in stock - Investing.com
There May Be Some Bright Spots In Zimmer Biomet Holdings' (NYSE:ZBH) Earnings - Yahoo Finance
FDA clears revision knee implant from Zimmer Biomet - Mass Device
Zimmer Biomet Says Tivanium Knee Implant Component Receives US FDA Clearance - Marketscreener.com
Zimmer Biomet Receives FDA Clearance For Persona® Revision Solution(TM) Femur -March 07, 2025 at 08:03 am EST - Marketscreener.com
Zimmer Biomet Receives FDA Clearance for Persona® Revision SoluTion™ Femur - GuruFocus.com
Dental Implant Market Forecast Report and Company Analysis 2025-2033 Featuring Danaher, Dentsply Sirona, Institut Straumann, Zimmer Biomet, Kyocera, Henry Schein, Biocon, and Osstem implant - Yahoo Finance UK
Can This New FDA-Cleared Knee Implant Solve the Metal Sensitivity Crisis? - StockTitan
Zimmer Biomet Holdings (NYSE:ZBH) Appoints Kristen Cardillo As Chief Communications Officer - Yahoo Finance
Zimmer Biomet Names Kristen Cardillo as Senior Vice President, C - GuruFocus.com
Zimmer Biomet Names Kristen Cardillo As Senior Vice President, Chief Communications Officer - Marketscreener.com
Zimmer Biomet Names Kristen Cardillo as Senior Vice President, Chief Communications Officer - PR Newswire
Zimmer Biomet Holdings, Inc. (ZBH): A Bull Case Theory - MSN
Knee Implants Market to Witness Remarkable Growth with Zimmer, Stryker, Smith & Nephew plc, Johnson & Johnson - openPR
Zimmer Biomet Holdings Inc Azioni (ZBH) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.19%
3.69%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):